Ledger.Open graph →
SEC Form D · Amendment · filed March 20, 2026

Averna Therapeutics Inc

Offering
$85.0M
Sold
$85.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Tal Zaks · Bothell, WAExec · DirectorStephen Squinto · HANOVER, NHDirectorThomas Barnes · Beloit, WIExec · DirectorNick Olsen · Jersey City, NJDirectorRaju Prasad · Watertown, MADirectorHenry Chen · Sunnyvale, CADirectorDylan Morris · Palo Alto, CADirectorRoy Amariglio · New York, NYDirectorMichal Silverberg · Menlo Park, CADirectorRichard Morris · 0001795222, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗